Lan G. Coffman, Ph.D. - Publications

2008 Wake Forest University School of Medicine, Winston-Salem, NC, United States 
Cell Biology, Molecular Biology, Oncology

8/29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Coffman LG, Burgos-Ojeda D, Wu R, Cho K, Bai S, Buckanovich RJ. New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 27083386 DOI: 10.1016/J.Trsl.2016.03.016  0.4
2015 Choi YJ, Ingram PN, Yang K, Coffman L, Iyengar M, Bai S, Thomas DG, Yoon E, Buckanovich RJ. Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2. Proceedings of the National Academy of Sciences of the United States of America. PMID 26621735 DOI: 10.1073/Pnas.1507899112  0.4
2011 Miller LD, Coffman LG, Chou JW, Black MA, Bergh J, D'Agostino R, Torti SV, Torti FM. An iron regulatory gene signature predicts outcome in breast cancer. Cancer Research. 71: 6728-37. PMID 21875943 DOI: 10.1158/0008-5472.Can-11-1870  0.4
2011 Miller LD, Coffman LG, Chou JW, Black MA, Bergh J, D'Agostino R, Torti SV, Torti FM. Abstract C64: Iron regulatory gene signature predicts outcome in breast cancer Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-C64  0.4
2010 Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: Past, present and future. Biochimica Et Biophysica Acta. 1800: 760-9. PMID 20304033 DOI: 10.1016/J.Bbagen.2010.03.011  0.4
2009 Coffman LG, Parsonage D, D'Agostino R, Torti FM, Torti SV. Regulatory effects of ferritin on angiogenesis. Proceedings of the National Academy of Sciences of the United States of America. 106: 570-5. PMID 19126685 DOI: 10.1073/Pnas.0812010106  0.4
2009 Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Reviews. 23: 95-104. PMID 18835072 DOI: 10.1016/J.Blre.2008.08.001  0.4
2008 Coffman LG, Brown JC, Johnson DA, Parthasarathy N, D'Agostino RB, Lively MO, Hua X, Tilley SL, Muller-Esterl W, Willingham MC, Torti FM, Torti SV. Cleavage of high-molecular-weight kininogen by elastase and tryptase is inhibited by ferritin. American Journal of Physiology. Lung Cellular and Molecular Physiology. 294: L505-15. PMID 18192590 DOI: 10.1152/Ajplung.00347.2007  0.4
Low-probability matches
2021 Ruffin AT, Cillo AR, Tabib T, Liu A, Onkar S, Kunning SR, Lampenfeld C, Atiya HI, Abecassis I, Kürten CHL, Qi Z, Soose R, Duvvuri U, Kim S, Oesterrich S, ... ... Coffman LG, et al. B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. Nature Communications. 12: 3349. PMID 34099645 DOI: 10.1038/s41467-021-23355-x  0.01
2021 Atiya HI, Orellana TJ, Wield A, Frisbie L, Coffman LG. An Orthotopic Mouse Model of Ovarian Cancer using Human Stroma to Promote Metastasis. Journal of Visualized Experiments : Jove. PMID 33843939 DOI: 10.3791/62382  0.01
2020 Fan H, Atiya HI, Wang Y, Pisanic TR, Wang TH, Shih IM, Foy KK, Frisbie L, Buckanovich RJ, Chomiak AA, Tiedemann RL, Rothbart SB, Chandler C, Shen H, Coffman LG. Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis. Cell Reports. 33: 108473. PMID 33296650 DOI: 10.1016/j.celrep.2020.108473  0.01
2020 Brown JR, Chan DK, Shank JJ, Griffith KA, Fan H, Szulawski R, Yang K, Reynolds RK, Johnston C, McLean K, Uppal S, Liu JR, Cabrera L, Taylor SE, Orr BC, ... ... Coffman L, et al. Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer. Jci Insight. PMID 32369446 DOI: 10.1172/Jci.Insight.133247  0.01
2020 Atiya H, Frisbie L, Pressimone C, Coffman L. Mesenchymal Stem Cells in the Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1234: 31-42. PMID 32040853 DOI: 10.1007/978-3-030-37184-5_3  0.01
2020 Goldfeld E, Atiya H, Frisbie L, Coffman LG. Defining the tumor cell: CA-MSC interactions which mediate ovarian cancer metastasis. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E18072  0.01
2020 Taylor SE, Wield A, Fang Y, Bhargava R, Lang S, Tseng G, Coffman LG, Oesterreich S. Endocrine biomarkers in low-grade serous ovarian cancers (LGSC) and serous ovarian tumors of low malignant potential (LMP). Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E18045  0.01
2020 Pressimone C, Atiya HI, Frisbie L, Coffman L. Abstract 1446: Mitochondrial transfer in the ovarian tumor microenvironment contributes to tumor stem cell phenotypes Immunology. DOI: 10.1158/1538-7445.Am2020-1446  0.01
2019 Bai S, Zhu W, Coffman L, Vlad A, Schwartz LE, Elishaev E, Drapkin R, Buckanovich RJ. CD105 Is Expressed in Ovarian Cancer Precursor Lesions and Is Required for Metastasis to the Ovary. Cancers. 11. PMID 31684072 DOI: 10.3390/Cancers11111710  0.01
2019 Chandler C, Liu T, Buckanovich R, Coffman LG. The double edge sword of fibrosis in cancer. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 30871956 DOI: 10.1016/J.Trsl.2019.02.006  0.01
2019 Frisbie LG, Shen H, Coffman L. Abstract TMIM-066: EZH2 REGULATES THE EPIGENETIC REPROGRAMMING OF OVARIAN CANCER PROMOTING CARCINOMA-ASSOCIATED MESENCHYMAL STEM CELLS Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Tmim-066  0.01
2019 Cillo AR, Chuckran CA, Liao M, Modugno F, Edwards R, Coffman L, Vignali DAA, Bruno TC. Abstract TMIM-063: TARGETING NEUROPILIN-1+ T REGULATORY CELLS IN PATIENTS WITH HIGH GRADE SEROUS OVARIAN CANCER DECREASES TREG-SPECIFIC SUPPRESSION OF CD8+ T CELLS Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Tmim-063  0.01
2018 Coffman LG, Pearson AT, Frisbie LG, Freeman Z, Christie E, Bowtell DD, Buckanovich RJ. Ovarian carcinoma-associated mesenchymal stem cells arise from tissue-specific normal stroma. Stem Cells (Dayton, Ohio). PMID 30353617 DOI: 10.1002/Stem.2932  0.01
2018 McLean K, Tan L, Bolland DE, Coffman LG, Peterson LF, Talpaz M, Neamati N, Buckanovich RJ. Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth. Oncogene. PMID 30305729 DOI: 10.1038/S41388-018-0523-6  0.01
2018 Iyengar M, O'Hayer P, Cole A, Sebastian T, Yang K, Coffman L, Buckanovich RJ. CDK4/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer. Oncotarget. 9: 15658-15672. PMID 29644000 DOI: 10.18632/Oncotarget.24585  0.01
2016 Coffman LG, Choi YJ, McLean K, Allen BL, di Magliano MP, Buckanovich RJ. Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop. Oncotarget. PMID 26755648 DOI: 10.18632/Oncotarget.6870  0.01
2016 Coffman LG, Choi Y, Mclean K, Magliano MPd, Allen B, Buckanovich RJ. Abstract B60: Identification of an ovarian tumor:stromal HH:BMP4 signaling loop critical to ovarian cancer growth and chemotherapy resistance. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B60  0.01
2016 Iyengar M, Coffman L, Buckanovich R. Abstract A73: CDK4/6 inhibition as maintenance therapy in ovarian cancer. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-A73  0.01
2013 Coffman L, Mooney C, Lim J, Bai S, Silva I, Gong Y, Yang K, Buckanovich RJ. Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cells. Cancer Biology & Therapy. 14: 184-92. PMID 23192269 DOI: 10.4161/Cbt.22959  0.01
2013 Coffman L, Choi Y, Buckanovich R. Abstract B72: Identification of hedgehog signaling between ovarian tumors and carcinoma associated mesenchymal stem cells Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-B72  0.01
Hide low-probability matches.